Skip to content

By playing, you agree to uListen's Terms and Privacy Policy and YouTube's Terms of Service.

Huberman LabHuberman Lab

Mushrooms for the Mind & Immune System | Paul Stamets

Paul Stamets is widely regarded as the father of modern applied mycology for his work on fungi and their applications in human health.

Nov 16, 20262h 28mWatch on YouTube

Summaries, chapters, transcripts, and FAQs on this page are made by uListen, not YouTube.

Great conversations run long. Their best ideas don't have to.

uListen is free on iPhone, iPad, Android, Chrome, and Claude.

See how

CHAPTERS

Jump to publisher timestamps

Chapter summaries

  1. Why pandemics aren’t over: natural immunity as a preparedness strategy

    Paul Stamets opens with concerns about future pandemics and argues that strengthening “natural immunity” matters because the immune system can generate tailored antibodies. He frames this as part of “natural intelligence” and the evolutionary logic of natural products working together.

    • •Paul Stamets says COVID is not the last pandemic and mentions H5N1 as a current concern
    • •He argues for “upregulating natural immunity” as a foundational defense
    • •He frames humans as “natural products” and emphasizes natural products used together as an evolutionary lesson
    • •He contrasts natural intelligence with artificial intelligence in the context of resilience and preparedness
  2. What fungi are: shared ancestry, multicellularity, and ecosystem-scale complexity

    Stamets explains fungi’s evolutionary relationship to animals and how fungal multicellularity enabled external digestion and absorption. He emphasizes the immense complexity of mycelial networks, soil microbiomes, and cooperative competition among organisms that supports ecosystems and, indirectly, health.

    • •Stamets describes a shared super-kingdom lineage with animals and how fungi diverged in nutrient processing
    • •He describes dense mycelial networks and microbial diversity in soil as a complex living system
    • •He discusses fungi’s role in structuring microbiomes and pushing back against pathogenic bacteria
    • •He argues that ecosystem complexity reflects “natural intelligence” and that humans are embedded in it
  3. Where fungi live and why mycelium matters more than mushrooms

    Andrew Huberman asks about fungal “architecture” and geography; Stamets replies that fungi are everywhere, including extreme ocean depths, and can even break through asphalt. He argues that mushrooms are just the visible “tip,” while mycelium functions as the core immune system of the fungal lifecycle and may hold major medical potential.

    • •Stamets says fungi can digest rock and concrete and describes mushrooms breaking through asphalt
    • •He notes marine mycology findings, including fungi deep in ocean cores
    • •He calls mushrooms the “tip of the iceberg,” with mycelium pervasive and foundational
    • •He claims mycelium is the immune system of the fungal lifecycle and central to future medicine
  4. Personal origin story: brotherhood, psilocybin curiosity, and falling in love with mushrooms

    Huberman asks how Stamets got interested in fungi; Stamets describes growing up with a scientifically minded brother who sparked his curiosity through stories of psilocybin. Stamets recounts searching for psychedelic mushrooms but finding edible mushrooms first, leading to a lifelong path in mycology and memories tied to his brother’s later passing.

    • •Stamets describes a home lab environment and early scientific influences from his brother John
    • •He says his brother’s stories about psilocybin motivated him to explore fungi
    • •He describes discovering edible mushrooms while searching for psilocybin mushrooms
    • •He links his brother’s death to his daily push-up practice later in life
  5. Primates, risk, and nutrition: why humans likely ate mushrooms early—and the danger of “delicious” toxins

    The discussion turns to how far back mushroom consumption goes; Stamets argues it likely extends to early primate history and notes many primates can distinguish edible from poisonous mushrooms. Huberman asks whether mushroom compounds could have influenced primate fetal development and brain evolution; Stamets says he doesn’t know, while warning that some deadly mushrooms can be delicious.

    • •Stamets says many primate species eat mushrooms and may learn what’s safe across generations
    • •He suggests early mushroom consumption could be driven by hunger and the presence of insect larvae
    • •Huberman asks about possible links between mushroom compounds, pregnancy nutrition, and brain evolution
    • •Stamets warns some of the deadliest mushrooms taste good and can be a person’s last meal
  6. From antivirals to biodefense: how mushroom research led to agarikon and turkey tail

    Stamets explains how his interest in antiviral mushrooms grew from early collaboration with a virologist and expanded after a literature survey he published. After 9/11, he says a biodefense effort tested many fungal extracts, and results drew attention—especially around the long-lived mushroom agarikon—setting the stage for later COVID-era research.

    • •Stamets recounts shipping mushrooms to a virologist who isolated an antiviral glycoprotein active against herpes viruses
    • •He says he published a survey of antiviral mushroom research, which later attracted biodefense interest
    • •He describes submitting large numbers of fungal samples for assays against weaponizable viruses
    • •He says agarikon emerged as especially important and notes its longevity and limited distribution
  7. COVID-era studies: vaccine enhancement, symptom reduction, and immune ‘readiness’

    Stamets describes clinical studies using agarikon and turkey tail mycelium-on-rice products, emphasizing the need to avoid overstimulating immunity. He reports findings of fewer adverse vaccine reactions, higher antibody reservoirs months later, and shorter symptom duration in COVID cases, while acknowledging that mechanisms are complex and still debated.

    • •Stamets explains regulators’ concern about cytokine storms and the need to avoid immune overstimulation
    • •He describes evidence of anti-inflammatory cytokine signaling in published work on mycelium-on-rice preparations
    • •He reports a double-blind, placebo-controlled vaccine study showing reduced adverse reactions and higher antibody reservoirs months later
    • •He describes a separate study in sick participants reporting reduced symptoms and shorter time to symptom reduction compared to placebo
  8. Mechanisms vs. outcomes: biological response modifiers, entourage effects, and strain selection

    Huberman presses on how fungi might work, including hormesis; Stamets responds with discussion of in vitro vs. in vivo evidence, broad gene-expression effects, and the “entourage” nature of natural products. He also describes searching for high-performing agarikon strains, retesting long-stored extracts, and the challenge of bio-guided fractionation losing activity when components are isolated.

    • •Stamets discusses in vitro findings where certain preparations dampen inflammation under LPS stress
    • •He describes large numbers of differentially expressed genes tied to immune effects and calls mushrooms biological response modifiers
    • •He explains how fractionating to single molecules can remove synergistic activity
    • •He describes strain hunting for “super strains,” plus retesting older extracts that still showed antiviral activity
  9. What Stamets personally takes: agarikon and turkey tail—plus sourcing, contamination, and dosing context

    Huberman asks for actionable protocols; Stamets describes what he personally uses and when, while emphasizing he can’t give medical recommendations. He also explains why lab-cultivated mycelium matters, including contamination issues with wild fruiting bodies and the functional differences of mycelium grown on grain or rice.

    • •Stamets describes taking agarikon and turkey tail products and differentiates maintenance vs. higher intake around public exposure
    • •He emphasizes cultivated, controlled production and raises concerns about contaminants and variability in wild-harvested mushrooms
    • •He describes mycelium-on-rice as a biotransformed (fermented) product distinct from fruiting bodies
    • •He points listeners to a reference site he curated that includes both supportive studies and reported adverse reactions
  10. Skeptics, regulation, and future threats: biodiversity as biosecurity (plus honeybee virus results)

    Stamets argues skepticism has helped strengthen his evidence base, but he criticizes regulatory frameworks that demand single-constituent characterization for natural products. He returns to pandemic risk—including H5N1 and bioweapon concerns—and says preserving biodiversity is essential for biosecurity, citing antiviral results in honeybees as another example of fungal extracts’ potential.

    • •Stamets says skeptics pushed him to produce peer-reviewed and placebo-controlled evidence
    • •He argues regulators create barriers by requiring characterization of too many constituents in complex natural products
    • •He reiterates concern about future pandemics and says preparedness requires strengthening immune readiness
    • •He describes work reporting large reductions of viral titers in honeybees after exposure to mushroom extracts
  11. Psilocybin’s resurgence: therapeutic potential, ‘heroic dose,’ and legal status

    The conversation shifts to psilocybin, with Stamets describing growing public use and clinical trial momentum for depression, PTSD, and other conditions. They outline what constitutes a “heroic dose,” emphasize legality concerns, and discuss heightened risks for people predisposed to psychosis or bipolar disorder.

    • •Stamets links increased use to clinical trials and growing evidence for neuroplasticity effects
    • •He defines “heroic dose” in terms of grams of common cultivated mushrooms and emphasizes preparation and support
    • •Huberman and Stamets emphasize psilocybin remains federally illegal, with some local decriminalization
    • •They highlight screening and caution for people at elevated risk of psychosis or bipolar disorder
  12. Therapeutic context and integration: why support before/during/after matters

    Huberman and Stamets discuss that plasticity is not enough without direction and integration, making therapy and preparation crucial. Stamets shares why he refused to guide close family and mentors through psilocybin sessions without adequate post-experience support, and he highlights a group-based model he views as effective.

    • •Huberman emphasizes directed plasticity and questions what good psychedelic therapy should include
    • •Stamets argues these are serious medicines and not party drugs, stressing adult supervision and screening
    • •He explains why he declined guiding two older father-figure experiences due to lack of integration support
    • •He describes a group-based therapeutic model where preparation and post-session community support are central
  13. Microdosing, medium dosing, and the ‘Stamets Stack’: definitions, study findings, and psychomotor measures

    Stamets defines microdosing as sub-perceptual and contrasts it with medium (“museum”) dosing and higher therapeutic dosing. He summarizes large observational studies and describes including a tapping test to capture psychomotor changes, then explains the rationale for combining psilocybin with niacin and lion’s mane in what he calls the “Stamets Stack.”

    • •Stamets defines microdose as below perceptual threshold and gives typical ranges in milligrams and mushroom amounts
    • •He distinguishes medium dosing (the “museum dose”) from full therapeutic dosing
    • •He summarizes observational study outcomes reporting improvements in depression, PTSD, and anxiety measures
    • •He describes a tapping test as a non-expectancy-linked measure and reports improved psychomotor performance in stack users
  14. Non-psychedelic cognition mushrooms: cordyceps, lion’s mane, reishi, and the limits of current evidence

    Huberman asks for practical top-level statements on cognition-related mushrooms; Stamets cautions about species complexity, especially in cordyceps research, and emphasizes that many effects require time rather than acute dosing. He also notes the funding barriers that limit larger clinical trials for natural products and distinguishes mushrooms like reishi as potentially more acute in sleep-related effects.

    • •Stamets says cordyceps is a complicated category with multiple species sometimes present together
    • •He describes evidence suggesting performance-related benefits may require weeks rather than immediate dosing
    • •He notes reishi (and lion’s mane) are often discussed in relation to sleep quality and neuroinflammation, while stressing limits of evidence
    • •He explains why Phase 2/3 trials are difficult to fund for natural products without IP protection
  15. Mycelial communication and ‘natural intelligence’: electrical signaling, interfaces, and a ‘tryptamine universe’

    They explore mycelium as a signaling network, with Stamets describing research on discrete electrical “word packets” in mycelial networks and speculating about future interfaces that could extend human sensing. He then shares a broader idea linking asteroidal chemistry and tryptophan to the notion of a universe rich in tryptamines and interconnected consciousness, while also calling for scientific stress-testing of big ideas.

    • •Stamets describes findings of electrical signaling patterns (“word packets”) in mycelium
    • •He speculates about wearable or shoe-based interfaces to connect with environmental signals via mycelium-like materials
    • •He discusses asteroid findings that included tryptophan and suggests broader implications for tryptamines in nature
    • •Both emphasize imagination paired with rigorous questioning and proof-seeking
  16. Fungi on and in the body: skin ecosystems, antifungals, and the dangers of disrupting balance

    Huberman asks about fungi living in and on humans; Stamets focuses on the skin mycobiome and warns that disrupting fungal balance—especially through antifungal drugs—can be dangerous. He acknowledges limits in his authority regarding gut fungi while emphasizing the importance of microbiome homeostasis and consulting domain experts.

    • •Stamets emphasizes fungi on the skin as part of a protective ecosystem
    • •He warns that certain antifungal interventions can disrupt homeostasis with severe consequences
    • •He notes fungi are closer to humans than many other organisms, complicating antifungal treatment safety
    • •He declines to speak authoritatively about internal gut fungi and encourages consulting specialists
  17. Mycoremediation reality check: what fungi can and can’t clean up

    Stamets describes where fungi are highly effective in remediation—such as breaking down hydrocarbons and filtering runoff bacteria—while offering a candid assessment of failures with dioxins, PCBs, and plastics in real-world ecosystems. He proposes rethinking mushroom farms as enzyme-rich remediation centers while explaining why fungi often choose easier “buffet” food sources over hard-to-degrade pollutants.

    • •Stamets says fungi can break down hydrocarbons (diesel, gasoline, oils) and reports successful applications
    • •He describes mycelium as a filtration membrane that can capture contaminants like E. coli in runoff
    • •He says remediation of dioxins/PCBs and plastics has been largely impractical in real ecosystems due to competing food sources
    • •He proposes mushroom farms as scalable sources of powerful enzyme-rich substrates for certain remediation tasks
  18. Push-ups, longevity, and closing reflections on curiosity, creativity, and legacy

    In the final segment, Stamets shares his long-running push-up practice and references a study he says links push-up capacity with lower cardiac event risk, while discussing aging without prescription drugs and feeling cognitively strong. Huberman and Stamets close by emphasizing creativity, respectful skepticism, collaboration, and responsibility to future generations, followed by Huberman’s standard show outro.

    • •Stamets shares his daily push-up practice and a long-standing competitive history with his twin brother
    • •He references a study he says links being able to do 40 push-ups with reduced cardiac risk
    • •He attributes feeling healthy and cognitively strong to lifestyle, curiosity, and his use of mushrooms (as an N-of-one perspective)
    • •They close by emphasizing respectful inquiry, collaboration, and intergenerational responsibility

Publisher timestamps

  1. 0:00Paul Stamets
  2. 3:25Fungal Evolution, Complexity; Natural Intelligence
  3. 10:02Fungi Geography, Mycelium & Immune System
  4. 15:10Sponsors: Eight Sleep & Our Place
  5. 17:43Journey into Mycology, Brother
  6. 21:14Primates & Eating Fungi, Poison; Nutrition, Fetal Health
  7. 25:14Medicinal Mushrooms, Antiviral Properties
  8. 30:26COVID Pandemic, Turkey Tail, Agarikon, Vaccine Enhancement
  9. 39:42Sponsor: AG1
  10. 40:33Enhance Immune System, Vaccines & Medicine, Agarikon, Entourage Effect
  11. 47:47Pharmaceuticals & Natural World
  12. 53:28Mushroom Supplements for Colds, Turkey Tail, Agarikon; Research
  13. 1:01:28Skeptics; Future Pandemics, H5N1, Biodiversity Importance, Natural Products
  14. 1:10:28Sponsor: Joovv
  15. 1:11:39Psilocybin, Depression, Heroic Dose
  16. 1:16:51Psilocybin, Legality, People with Increased Risk, Benefits
  17. 1:21:41Psychedelic Therapies, Neuroplasticity, Therapeutic Support
  18. 1:27:36Psychedelics & Legalization; Psilocybin
  19. 1:34:35Sponsor: Function
  20. 1:36:12Kids, Psilocybin; Microdose, Pharmaceutical Version vs Mushroom
  21. 1:42:11Microdose, Doses; Sensory Perception
  22. 1:48:14Microdosing, Stamets Stack, Mood, Anxiety, Psychomotor Benefits
  23. 1:54:10Cognitive Mushroom Supplements, Cordyceps, Lion’s Mane, Reishi
  24. 1:59:55Mycelium Networks, Electrical Communication; Asteroid, Tryptamine
  25. 2:09:48Fungi on Skin & Gut, Antifungals
  26. 2:13:28Mycoremediation, Fungi & Environmental Pollutants
  27. 2:19:27Tool: Push-Ups; Longevity, Creativity, Happiness
  28. 2:27:01Zero-Cost Support, YouTube, Spotify & Apple Follow, Reviews & Feedback, Sponsors, Social Media, Neural Network Newsletter

Get more out of YouTube videos.

Read along on your phone, search it beside the video, or ask your favorite AI app what was said.